Open AccessManagment of Relapsed/Refractory ALL With Inotuzumab During COVID-19. A Casr Report
Author(s) -
Martina Di Palma,
Elio Gentilini,
Chiara Masucci,
Alessandra Micozzi,
Ombretta Turriziani,
Antonino Mulè,
Robin Foà,
Maurizio Martelli,
Gabriella d’Ettorre,
Saveria Capria,
Sabina Chiaretti
Publication year - 2022
Publication title -
mediterranean journal of hematology and infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 31
ISSN - 2035-3006
DOI - 10.4084/mjhid.2022.043
Subject(s) - medicine , asymptomatic , refractory (planetary science) , concomitant , covid-19 , viral load , pediatrics , immunology , human immunodeficiency virus (hiv) , physics , disease , astrobiology , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom